市場調査レポート

商品コード

日光角化症治療の世界市場規模、シェア、産業動向分析レポート：薬剤クラス別、治療法別、最終用途別、地域別展望と予測、2022年～2028年

Global Actinic Keratosis Treatment Market Size, Share & Industry Trends Analysis Report By Drug Class, By Therapy, By End-use, By Regional Outlook and Forecast, 2022 - 2028

出版日: 2022年11月30日 | 発行: KBV Research

| ページ情報: 英文 224 Pages | 納期: 即納可能

価格

PDF (Single User License)

USD 3,600 564,336円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 4,320 677,203円

レポートPDFを同一企業内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprisewide License)

USD 6,048 948,084円

レポートPDFを同一企業のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の日光角化症治療市場規模は、予測期間中にCAGR4.4％で成長し、2028年には80億米ドルに達すると予測されています。

皮膚の前がんである日光角化症（AK）は、かなり広く存在しています。AKの危険因子と原因を知ることは、個人がAKの発生を阻止するのに役立ちます。病気のリスクを知っていれば、非常に治りやすいAKを早期に発見することが容易になります。日光への暴露は、累積的な皮膚損傷を引き起こします。このことは、たとえ短時間であっても、長時間日光に当たれば当たるほど、AKの発症リスクが高まることを意味します。

日光の下で外仕事をする人、薄毛の人、日焼けのある人などがこれにあたります。特に屋内の日焼けマシンが発する紫外線は、AKなどの皮膚がんのリスクを高めるので危険です。また、一年中紫外線が強い赤道付近では、より多くの人が紫外線の害を受けることになります。したがって、赤道付近に住んでいる人は、AKを発症する確率が高くなります。

COVID-19影響度分析

COVID-19のパンデミックによる影響としては、サプライチェーンの大幅な停滞、株式市場の変動、企業モラルの低下、国民の将来に対する混乱と不安の高まりなどが挙げられます。日光角化症治療市場においては、パンデミックはマイナスの影響を及ぼしました。大多数の国で完全閉鎖され、必要以外の医師の訪問が制限された結果、診断率と治療率は著しく低下しました。また、ほとんどの病院では、皮膚科医との継続的なコミュニケーションを維持し、日光角化症やその他の緊急性のない医療問題で受診する患者を減らすことができました。しかし、COVID-19の制限が全体的に緩和されるにつれて、日光角化症治療の市場は上昇すると予想されます。

市場の成長要因

低侵襲性臨床処置の使用の増加

オゾン層の破壊と長時間の日光浴の結果として、日光角化症が広く見られるようになりました。がん患者の増加や低侵襲（MI）治療への強い要望が高まっています。日光角化症はより一般的になると予測され、また、病気の管理方法に対する人々の意識が高まるにつれ、治療に対するニーズも高まると思われます。日光角化症の治療に対する需要は、その悪影響に対する人々の認識が高まるにつれて高まっています。さらに、日光角化症に関連した皮膚がんの発症リスクが高いため、診断や治療の頻度が高まっています。

政府の取り組みが拡大し、購入しやすい価格へ

日光角化症治療を受ける患者数は、医療機関へのアクセスや医療費の負担を軽減するための政府の取り組みにも影響を受けています。今後数年間は、魅力的なリベート制度が利用可能になることで、需要の拡大が見込まれます。世界中で、多くの公的・私的団体が、日光角化症治療の選択肢に関する一般市民の知識を高めようと試みています。さらに、日光角化症治療は、より高い有効性、便利な服用方法、安価な価格設定を備えた新薬の研究開発プロジェクトに多額の投資を行い、成長を続けています。

市場の抑制要因

治療法の普及率の低さと有資格の専門医の不足

日光角化症の治療で最も重要なのは、抑制と治癒のための効果的な方法です。調査や実験により、凍結療法や光線力学的療法などの方法が、日光角化症の管理に最も効果的であることが示されています。しかし、資格を持った医療従事者の不足が深刻で、増え続ける患者さんと治療できる医師との間のギャップが大きくなっています。ケミカルピーリングによる日光角化症の治療においても、医療従事者や外科医などの有資格者が必要です。

治療法の展望

日光角化症治療市場は、治療法に基づいて局所療法、光線力学的療法、手術に分類されます。光線力学療法セグメントは、2021年の日光角化症治療市場で大きな収益シェアを示しました。光障害、前がん性シミ、その他の皮膚障害に対する非侵襲的な治療法として、光力学的青色光治療があります。光に反応する薬剤であるアミノレブリン酸を、治療対象のシミに塗布します。その後、治療部位に照射される青色光によって、標的となる細胞を消滅させます。広い範囲を効果的に治療することができます。

薬物クラスの展望

薬剤の種類によって、日光角化症治療市場は、ヌクレオシド代謝阻害剤、NSAIDs、免疫反応修飾剤、光線強化剤、その他に分類されます。NSAIDsセグメントは、2021年の日光角化症治療市場において、かなりの収益シェアを記録しています。非ステロイド性抗炎症薬（NSAIDs）は、COXアイソフォームを非可逆的または可逆的にアセチル化し、下流のプロスタグランジンをブロックし、皮膚がんなどの悪性腫瘍の場合には化学予防薬として作用する可能性があります。

最終用途の展望

日光角化症治療市場は、最終用途に基づき、病院、個人クリニック、在宅医療、その他に区分されます。2021年の日光角化症治療市場では、ホームケアセグメントが大きな収益シェアを獲得しています。外用治療薬の使用量の増加、患者の快適性要因、市販（OTC）製品の入手しやすさ、外用製品の発売数の拡大などが、ホームケア分野の拡大に寄与しているものと思われます。

地域別の展望

日光角化症治療市場は、地域別に北米、欧州、アジア太平洋、LAMEAで分析されています。北米セグメントは、2021年の日光角化症治療市場で最も高い収益シェアを獲得しました。日光角化症の発生率の増加、政府の奨励策、消費者の意識の向上、ヘルスケアインフラの改善、継続的な技術的ブレークスルーなどが上昇の要因として挙げられます。また、事業成長の主な原因の1つは、北米の市場における重要なプレイヤーの存在です。

市場の定義
目的
市場規模
セグメンテーション
- 日光角化症治療の世界市場、薬剤クラス別
- 日光角化症治療の世界市場：治療法別
- 日光角化症治療の世界市場：エンドユース別
- 日光角化症治療の世界市場：地域別
調査手法

第2章市場概要

イントロダクション
- 概要説明
  - 市場の構成とシナリオ
市場に影響を与える主な要因
- 市場促進要因
- 市場抑制要因

第3章日光角化症治療の世界市場：薬物クラス別

ヌクレオシド代謝阻害剤の世界市場：地域別
NSAIDsの世界市場：地域別
免疫反応修飾剤の世界市場：地域別
光線硬化剤の世界市場：地域別
その他の地域別世界市場

第4章日光角化症治療の世界市場：治療法別

手術の世界市場：地域別
局所療法の世界市場：地域別
光線力学療法の世界市場：地域別

第5章光線力学療法の世界市場：エンドユーザー別

病院の世界市場：地域別
個人クリニックの世界市場：地域別
ホームケアの世界市場：地域別
その他の地域別世界市場

第6章日光角化症治療の世界市場：地域別市場

北米
- 北米の日光角化症治療の国別市場
  - 米国
  - カナダ
  - メキシコ
  - その他北米地域
欧州
- 欧州の日光角化症治療市場：国別
  - ドイツ
  - 英国
  - フランス
  - ロシア
  - スペイン
  - イタリア
  - その他欧州
アジア太平洋地域
- アジア太平洋地域の日光角化症治療の国別市場
  - 中国
  - 日本
  - インド
  - 韓国
  - シンガポール
  - マレーシア
  - その他アジア太平洋地域
LAMEA
- LAMEAの日光角化症治療市場：国別
  - ブラジル
  - アルゼンチン
  - UAE
  - サウジアラビア
  - 南アフリカ
  - ナイジェリア
  - その他のLAMEA

第7章企業プロファイル

Almirall, S.A
LEO Pharma A/S
Biofrontera AG
Sun Pharmaceuticals Industries Ltd.
3M Company
Bausch Health Companies, Inc.
Novartis AG
Viatris, Inc.
Galderma S.A

図表

LIST OF TABLES

TABLE 1 Global Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 2 Global Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 3 Global Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 4 Global Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 5 Global Nucleoside Metabolic Inhibitor Market by Region, 2018 - 2021, USD Million
TABLE 6 Global Nucleoside Metabolic Inhibitor Market by Region, 2022 - 2028, USD Million
TABLE 7 Global NSAIDs Market by Region, 2018 - 2021, USD Million
TABLE 8 Global NSAIDs Market by Region, 2022 - 2028, USD Million
TABLE 9 Global Immune Response Modifiers Market by Region, 2018 - 2021, USD Million
TABLE 10 Global Immune Response Modifiers Market by Region, 2022 - 2028, USD Million
TABLE 11 Global Photoenhancers Market by Region, 2018 - 2021, USD Million
TABLE 12 Global Photoenhancers Market by Region, 2022 - 2028, USD Million
TABLE 13 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 14 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 15 Global Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 16 Global Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 17 Global Surgery Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Surgery Market by Region, 2022 - 2028, USD Million
TABLE 19 Global Topical Market by Region, 2018 - 2021, USD Million
TABLE 20 Global Topical Market by Region, 2022 - 2028, USD Million
TABLE 21 Global Photodynamic Therapy Market by Region, 2018 - 2021, USD Million
TABLE 22 Global Photodynamic Therapy Market by Region, 2022 - 2028, USD Million
TABLE 23 Global Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 24 Global Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 25 Global Hospitals Market by Region, 2018 - 2021, USD Million
TABLE 26 Global Hospitals Market by Region, 2022 - 2028, USD Million
TABLE 27 Global Private Clinics Market by Region, 2018 - 2021, USD Million
TABLE 28 Global Private Clinics Market by Region, 2022 - 2028, USD Million
TABLE 29 Global Homecare Market by Region, 2018 - 2021, USD Million
TABLE 30 Global Homecare Market by Region, 2022 - 2028, USD Million
TABLE 31 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 32 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 33 Global Actinic Keratosis Treatment Market by Region, 2018 - 2021, USD Million
TABLE 34 Global Actinic Keratosis Treatment Market by Region, 2022 - 2028, USD Million
TABLE 35 North America Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 36 North America Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 37 North America Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 38 North America Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 39 North America Nucleoside Metabolic Inhibitor Market by Country, 2018 - 2021, USD Million
TABLE 40 North America Nucleoside Metabolic Inhibitor Market by Country, 2022 - 2028, USD Million
TABLE 41 North America NSAIDs Market by Country, 2018 - 2021, USD Million
TABLE 42 North America NSAIDs Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Immune Response Modifiers Market by Country, 2018 - 2021, USD Million
TABLE 44 North America Immune Response Modifiers Market by Country, 2022 - 2028, USD Million
TABLE 45 North America Photoenhancers Market by Country, 2018 - 2021, USD Million
TABLE 46 North America Photoenhancers Market by Country, 2022 - 2028, USD Million
TABLE 47 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 48 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 49 North America Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 50 North America Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 51 North America Surgery Market by Country, 2018 - 2021, USD Million
TABLE 52 North America Surgery Market by Country, 2022 - 2028, USD Million
TABLE 53 North America Topical Market by Country, 2018 - 2021, USD Million
TABLE 54 North America Topical Market by Country, 2022 - 2028, USD Million
TABLE 55 North America Photodynamic Therapy Market by Country, 2018 - 2021, USD Million
TABLE 56 North America Photodynamic Therapy Market by Country, 2022 - 2028, USD Million
TABLE 57 North America Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 58 North America Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 59 North America Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 60 North America Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 61 North America Private Clinics Market by Country, 2018 - 2021, USD Million
TABLE 62 North America Private Clinics Market by Country, 2022 - 2028, USD Million
TABLE 63 North America Homecare Market by Country, 2018 - 2021, USD Million
TABLE 64 North America Homecare Market by Country, 2022 - 2028, USD Million
TABLE 65 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 66 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 67 North America Actinic Keratosis Treatment Market by Country, 2018 - 2021, USD Million
TABLE 68 North America Actinic Keratosis Treatment Market by Country, 2022 - 2028, USD Million
TABLE 69 US Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 70 US Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 71 US Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 72 US Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 73 US Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 74 US Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 75 US Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 76 US Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 77 Canada Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 78 Canada Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 79 Canada Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 80 Canada Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 81 Canada Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 82 Canada Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 83 Canada Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 84 Canada Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 85 Mexico Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 86 Mexico Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 87 Mexico Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 88 Mexico Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 89 Mexico Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 90 Mexico Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 91 Mexico Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 92 Mexico Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 93 Rest of North America Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 94 Rest of North America Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 95 Rest of North America Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 96 Rest of North America Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 97 Rest of North America Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 98 Rest of North America Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 99 Rest of North America Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 100 Rest of North America Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 101 Europe Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 102 Europe Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 103 Europe Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 104 Europe Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 105 Europe Nucleoside Metabolic Inhibitor Market by Country, 2018 - 2021, USD Million
TABLE 106 Europe Nucleoside Metabolic Inhibitor Market by Country, 2022 - 2028, USD Million
TABLE 107 Europe NSAIDs Market by Country, 2018 - 2021, USD Million
TABLE 108 Europe NSAIDs Market by Country, 2022 - 2028, USD Million
TABLE 109 Europe Immune Response Modifiers Market by Country, 2018 - 2021, USD Million
TABLE 110 Europe Immune Response Modifiers Market by Country, 2022 - 2028, USD Million
TABLE 111 Europe Photoenhancers Market by Country, 2018 - 2021, USD Million
TABLE 112 Europe Photoenhancers Market by Country, 2022 - 2028, USD Million
TABLE 113 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 114 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 115 Europe Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 116 Europe Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 117 Europe Surgery Market by Country, 2018 - 2021, USD Million
TABLE 118 Europe Surgery Market by Country, 2022 - 2028, USD Million
TABLE 119 Europe Topical Market by Country, 2018 - 2021, USD Million
TABLE 120 Europe Topical Market by Country, 2022 - 2028, USD Million
TABLE 121 Europe Photodynamic Therapy Market by Country, 2018 - 2021, USD Million
TABLE 122 Europe Photodynamic Therapy Market by Country, 2022 - 2028, USD Million
TABLE 123 Europe Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 124 Europe Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 125 Europe Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 126 Europe Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 127 Europe Private Clinics Market by Country, 2018 - 2021, USD Million
TABLE 128 Europe Private Clinics Market by Country, 2022 - 2028, USD Million
TABLE 129 Europe Homecare Market by Country, 2018 - 2021, USD Million
TABLE 130 Europe Homecare Market by Country, 2022 - 2028, USD Million
TABLE 131 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 132 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 133 Europe Actinic Keratosis Treatment Market by Country, 2018 - 2021, USD Million
TABLE 134 Europe Actinic Keratosis Treatment Market by Country, 2022 - 2028, USD Million
TABLE 135 Germany Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 136 Germany Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 137 Germany Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 138 Germany Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 139 Germany Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 140 Germany Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 141 Germany Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 142 Germany Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 143 UK Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 144 UK Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 145 UK Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 146 UK Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 147 UK Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 148 UK Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 149 UK Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 150 UK Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 151 France Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 152 France Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 153 France Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 154 France Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 155 France Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 156 France Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 157 France Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 158 France Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 159 Russia Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 160 Russia Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 161 Russia Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 162 Russia Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 163 Russia Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 164 Russia Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 165 Russia Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 166 Russia Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 167 Spain Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 168 Spain Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 169 Spain Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 170 Spain Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 171 Spain Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 172 Spain Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 173 Spain Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 174 Spain Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 175 Italy Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 176 Italy Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 177 Italy Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 178 Italy Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 179 Italy Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 180 Italy Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 181 Italy Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 182 Italy Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 183 Rest of Europe Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 184 Rest of Europe Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 185 Rest of Europe Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 186 Rest of Europe Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 187 Rest of Europe Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 188 Rest of Europe Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 189 Rest of Europe Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 190 Rest of Europe Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 191 Asia Pacific Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 192 Asia Pacific Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 193 Asia Pacific Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 194 Asia Pacific Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 195 Asia Pacific Nucleoside Metabolic Inhibitor Market by Country, 2018 - 2021, USD Million
TABLE 196 Asia Pacific Nucleoside Metabolic Inhibitor Market by Country, 2022 - 2028, USD Million
TABLE 197 Asia Pacific NSAIDs Market by Country, 2018 - 2021, USD Million
TABLE 198 Asia Pacific NSAIDs Market by Country, 2022 - 2028, USD Million
TABLE 199 Asia Pacific Immune Response Modifiers Market by Country, 2018 - 2021, USD Million
TABLE 200 Asia Pacific Immune Response Modifiers Market by Country, 2022 - 2028, USD Million
TABLE 201 Asia Pacific Photoenhancers Market by Country, 2018 - 2021, USD Million
TABLE 202 Asia Pacific Photoenhancers Market by Country, 2022 - 2028, USD Million
TABLE 203 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 204 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 205 Asia Pacific Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 206 Asia Pacific Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 207 Asia Pacific Surgery Market by Country, 2018 - 2021, USD Million
TABLE 208 Asia Pacific Surgery Market by Country, 2022 - 2028, USD Million
TABLE 209 Asia Pacific Topical Market by Country, 2018 - 2021, USD Million
TABLE 210 Asia Pacific Topical Market by Country, 2022 - 2028, USD Million
TABLE 211 Asia Pacific Photodynamic Therapy Market by Country, 2018 - 2021, USD Million
TABLE 212 Asia Pacific Photodynamic Therapy Market by Country, 2022 - 2028, USD Million
TABLE 213 Asia Pacific Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 214 Asia Pacific Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 215 Asia Pacific Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 216 Asia Pacific Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 217 Asia Pacific Private Clinics Market by Country, 2018 - 2021, USD Million
TABLE 218 Asia Pacific Private Clinics Market by Country, 2022 - 2028, USD Million
TABLE 219 Asia Pacific Homecare Market by Country, 2018 - 2021, USD Million
TABLE 220 Asia Pacific Homecare Market by Country, 2022 - 2028, USD Million
TABLE 221 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 222 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 223 Asia Pacific Actinic Keratosis Treatment Market by Country, 2018 - 2021, USD Million
TABLE 224 Asia Pacific Actinic Keratosis Treatment Market by Country, 2022 - 2028, USD Million
TABLE 225 China Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 226 China Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 227 China Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 228 China Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 229 China Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 230 China Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 231 China Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 232 China Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 233 Japan Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 234 Japan Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 235 Japan Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 236 Japan Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 237 Japan Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 238 Japan Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 239 Japan Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 240 Japan Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 241 India Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 242 India Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 243 India Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 244 India Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 245 India Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 246 India Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 247 India Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 248 India Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 249 South Korea Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 250 South Korea Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 251 South Korea Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 252 South Korea Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 253 South Korea Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 254 South Korea Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 255 South Korea Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 256 South Korea Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 257 Singapore Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 258 Singapore Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 259 Singapore Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 260 Singapore Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 261 Singapore Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 262 Singapore Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 263 Singapore Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 264 Singapore Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 265 Malaysia Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 266 Malaysia Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 267 Malaysia Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 268 Malaysia Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 269 Malaysia Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 270 Malaysia Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 271 Malaysia Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 272 Malaysia Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 273 Rest of Asia Pacific Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 274 Rest of Asia Pacific Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 275 Rest of Asia Pacific Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 276 Rest of Asia Pacific Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 277 Rest of Asia Pacific Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 278 Rest of Asia Pacific Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 279 Rest of Asia Pacific Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 280 Rest of Asia Pacific Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 281 LAMEA Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 282 LAMEA Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 283 LAMEA Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 284 LAMEA Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 285 LAMEA Nucleoside Metabolic Inhibitor Market by Country, 2018 - 2021, USD Million
TABLE 286 LAMEA Nucleoside Metabolic Inhibitor Market by Country, 2022 - 2028, USD Million
TABLE 287 LAMEA NSAIDs Market by Country, 2018 - 2021, USD Million
TABLE 288 LAMEA NSAIDs Market by Country, 2022 - 2028, USD Million
TABLE 289 LAMEA Immune Response Modifiers Market by Country, 2018 - 2021, USD Million
TABLE 290 LAMEA Immune Response Modifiers Market by Country, 2022 - 2028, USD Million
TABLE 291 LAMEA Photoenhancers Market by Country, 2018 - 2021, USD Million
TABLE 292 LAMEA Photoenhancers Market by Country, 2022 - 2028, USD Million
TABLE 293 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 294 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 295 LAMEA Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 296 LAMEA Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 297 LAMEA Surgery Market by Country, 2018 - 2021, USD Million
TABLE 298 LAMEA Surgery Market by Country, 2022 - 2028, USD Million
TABLE 299 LAMEA Topical Market by Country, 2018 - 2021, USD Million
TABLE 300 LAMEA Topical Market by Country, 2022 - 2028, USD Million
TABLE 301 LAMEA Photodynamic Therapy Market by Country, 2018 - 2021, USD Million
TABLE 302 LAMEA Photodynamic Therapy Market by Country, 2022 - 2028, USD Million
TABLE 303 LAMEA Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 304 LAMEA Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 305 LAMEA Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 306 LAMEA Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 307 LAMEA Private Clinics Market by Country, 2018 - 2021, USD Million
TABLE 308 LAMEA Private Clinics Market by Country, 2022 - 2028, USD Million
TABLE 309 LAMEA Homecare Market by Country, 2018 - 2021, USD Million
TABLE 310 LAMEA Homecare Market by Country, 2022 - 2028, USD Million
TABLE 311 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 312 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 313 LAMEA Actinic Keratosis Treatment Market by Country, 2018 - 2021, USD Million
TABLE 314 LAMEA Actinic Keratosis Treatment Market by Country, 2022 - 2028, USD Million

TABLE 315 Brazil Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 316 Brazil Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 317 Brazil Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 318 Brazil Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 319 Brazil Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 320 Brazil Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 321 Brazil Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 322 Brazil Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 323 Argentina Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 324 Argentina Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 325 Argentina Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 326 Argentina Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 327 Argentina Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 328 Argentina Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 329 Argentina Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 330 Argentina Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 331 UAE Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 332 UAE Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 333 UAE Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 334 UAE Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 335 UAE Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 336 UAE Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 337 UAE Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 338 UAE Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 339 Saudi Arabia Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 340 Saudi Arabia Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 341 Saudi Arabia Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 342 Saudi Arabia Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 343 Saudi Arabia Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 344 Saudi Arabia Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 345 Saudi Arabia Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 346 Saudi Arabia Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 347 South Africa Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 348 South Africa Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 349 South Africa Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 350 South Africa Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 351 South Africa Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 352 South Africa Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 353 South Africa Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 354 South Africa Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 355 Nigeria Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 356 Nigeria Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 357 Nigeria Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 358 Nigeria Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 359 Nigeria Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 360 Nigeria Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 361 Nigeria Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 362 Nigeria Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 363 Rest of LAMEA Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 364 Rest of LAMEA Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 365 Rest of LAMEA Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 366 Rest of LAMEA Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 367 Rest of LAMEA Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 368 Rest of LAMEA Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 369 Rest of LAMEA Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 370 Rest of LAMEA Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 371 Key Information - Almirall, S.A
TABLE 372 key information - LEO Pharma A/S
TABLE 373 Key Information - Biofrontera AG
TABLE 374 Key Information - Sun Pharmaceuticals Industries Ltd.
TABLE 375 Key Information - 3M Company
TABLE 376 key information - Bausch Health Companies, Inc.
TABLE 377 Key Information - Novartis AG
TABLE 378 key information - Viatris, Inc.
TABLE 379 Key Information - Galderma S.A.

List of Figures

FIG 1 Methodology for the research
FIG 2 Global Actinic Keratosis Treatment Market Share by Drug Class, 2021
FIG 3 Global Actinic Keratosis Treatment Market Share by Drug Class, 2028
FIG 4 Global Actinic Keratosis Treatment Market by Drug Class, 2018 - 2028, USD Million
FIG 5 Global Actinic Keratosis Treatment Market Share by Therapy, 2021
FIG 6 Global Actinic Keratosis Treatment Market Share by Therapy, 2028
FIG 7 Global Actinic Keratosis Treatment Market by Therapy, 2018 - 2028, USD Million
FIG 8 Global Actinic Keratosis Treatment Market Share by End-use, 2021
FIG 9 Global Actinic Keratosis Treatment Market Share by End-use, 2028
FIG 10 Global Actinic Keratosis Treatment Market by End-use, 2018 - 2028, USD Million
FIG 11 Global Actinic Keratosis Treatment Market Share by Region, 2021
FIG 12 Global Actinic Keratosis Treatment Market Share by Region, 2028
FIG 13 Global Actinic Keratosis Treatment Market by Region, 2018 - 2028, USD Million
FIG 14 Recent strategies and developments: Almirall, S.A
FIG 15 SWOT Analysis: 3M Company

The Global Actinic Keratosis Treatment Market size is expected to reach $8 billion by 2028, rising at a market growth of 4.4% CAGR during the forecast period.

Actinic keratosis is the most frequent precancer that develops on skin that has been chronically damaged by ultraviolet rays emitted by the sun or/and indoor tanning. This disorder is also referred to as solar keratosis. If someone already has an AK, they are more likely to go on to acquire further actinic keratoses. Since AKs can turn into squamous cell carcinoma (SCC), a frequent and occasionally invasive form of the illness, this increases the risk of developing skin cancer.

Squamous cells, one of the three primary cell types in the epidermis, are flat cells close to the skin's surface that continuously shed as new ones develop. Squamous cell carcinoma (SCC) develops when aberrant squamous cell alterations result from DNA damage brought on by exposure to UV radiation or other harmful factors. SCCs can manifest as elevated developments with a central depression, open sores, scaly red patches, and rough, thickened, or wart-like skin. SCCs can develop in various additional body parts, including the genitalia.

The skin precancer actinic keratosis is quite widespread. Knowing the risk factors and the causes of AK can assist individuals to stop it from happening. It is easier for people to identify AKs early on when they are very curable if they are aware of the disease risk. Sun exposure causes cumulative skin damage. This implies that the risk of developing AKs increases the longer people stay in the sun over time, even for small durations.

This includes persons who work outside in the sunlight, those who have thinning hair or a bald head, and those with sunburns. The UV rays that indoor tanning beds emit are particularly hazardous since they increase the risk of getting AKs and other forms of skin cancer. More people are exposed to the damaging effects of the sun when they live near the equator where UV rays are high for most of the year. Therefore, those who reside in areas near the equator have a higher chance of developing AKs.

COVID-19 Impact Analysis

A significant slowdown in the supply chain, stock market volatility, deterioration in corporate morale, and rising public confusion and fear about the future are just a few of the many effects of the COVID-19 pandemic. On the actinic keratosis treatments market, the pandemic had a negative effect. Diagnose and treatment rates were significantly lower as a result of total lockdown in the majority of nations and restrictions on non-essential doctor visits. Additionally, most hospitals maintained ongoing communication with dermatologists to reduce the number of patients who visited with actinic keratosis and other non-urgent medical issues. However, the market for actinic keratosis treatments is anticipated to rise as COVID-19 limits are loosened across the board.

Market Growth Factors

The Increased Use Of Minimally Invasive Clinical Procedures

There is a high prevalence of actinic keratosis as a consequence of ozone layer degradation and prolonged sun exposure. Increasing cancer cases and a strong desire for minimally invasive (MI) therapies are growing. Actinic keratosis is projected to become more common, and there will also be a greater need for therapies as people become more aware of how to manage their illnesses. The demand for actinic keratosis treatment is rising as people become more aware of its negative effects. Additionally, the frequency of identification and treatment has increased because of the higher risk of developing skin cancer linked to actinic keratosis.

Expanding Government Initiatives To Increase Affordability

The number of patients undergoing actinic keratosis therapy has also been impacted by government initiatives to increase access to and affordability of healthcare facilities. In the coming years, the availability of alluring rebate programs is anticipated to stimulate demand development. Around the world, a number of public and private groups are attempting to increase public knowledge of actinic keratosis treatment options. Furthermore, actinic keratosis treatments are growing along with significant investments in research & development projects to produce novel medications with higher efficacy, convenient dosage, and cheaper pricing.

Market Restraining Factors

Low Treatment Penetration And A Lack Of Qualified Specialists

The most important factor for the treatment of actinic keratosis is an effective method to control and cure it. Research and experiments have shown methods like cryotherapy and photodynamic therapy to be most effective in managing actinic keratosis. But the severe lack of qualified healthcare professionals increases the gap between the growing number of patients and the doctors who can treat it. Even for the treatment of actinic keratosis by chemical peels, qualified medical personnel and surgeons are required.

Therapy Outlook

Based on therapy, the actinic keratosis treatment market is categorized into topical, photodynamic therapy, and surgery. The photodynamic segment witnessed a significant revenue share in the actinic keratosis treatment market in 2021. A non-invasive treatment for photodamage, precancerous spots, and other skin disorders is photodynamic blue light therapy. Aminolevulinic acid, a drug that reacts to light, is applied to the spot being treated. The targeted cells are then obliterated by a blue light that is then focused on the therapy area. Large regions can be effectively treated in this way.

Drug Class Outlook

On the basis of drug class, the actinic keratosis treatment market is divided into nucleoside metabolic inhibitor, NSAIDs, immune response modifiers, photoenhancers, and others. The NSAIDs segment recorded a substantial revenue share in the actinic keratosis treatment market in 2021. Non-steroidal anti-inflammatory medicines (NSAIDs) work by irreversibly or reversibly acetylating COX isoforms, blocking downstream prostaglandins, and possibly acting as chemopreventatives in the case of malignancies like skin cancer.

End-Use Outlook

Based on end-use, the actinic keratosis treatment market is segmented into hospitals, private clinics, homecare, and others. The homecare segment acquired a significant revenue share in the actinic keratosis treatment market in 2021. The increasing usage of topical treatments, patient comfort factors, the accessibility of over-the-counter (OTC) products, and the expanding number of topical product launches are all factors contributing to the expansion of the homecare segment.

Regional Outlook

On the basis of region, the actinic keratosis treatment market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment garnered the highest revenue share in the actinic keratosis treatment market in 2021. Actinic keratosis' increasing incidence, encouraging government measures, more consumer awareness, better healthcare infrastructure improvements, and continued technical breakthroughs are all credited with the rise. One of the main causes of business growth is also the existence of important players in the market in North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Almirall, S.A, LEO Pharma A/S, Biofrontera AG, Sun Pharmaceuticals Industries Ltd., 3M Company, Bausch Health Companies, Inc., Novartis AG, Viatris, Inc., and Galderma S.A.

Scope of the Study

Market Segments covered in the Report:

By Drug Class

Nucleoside Metabolic Inhibitor
NSAIDs
Immune Response Modifiers
Photoenhancers
Others

By Therapy

Surgery
Topical
Photodynamic Therapy

By End-use

Hospitals
Private Clinics
Homecare
Others

By Geography

North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA

Companies Profiled

Almirall, S.A
LEO Pharma A/S
Biofrontera AG
Sun Pharmaceuticals Industries Ltd.
3M Company
Bausch Health Companies, Inc.
Novartis AG
Viatris, Inc.
Galderma S.A.

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Global Actinic Keratosis Treatment Market, by Drug Class
- 1.4.2 Global Actinic Keratosis Treatment Market, by Therapy
- 1.4.3 Global Actinic Keratosis Treatment Market, by End-use
- 1.4.4 Global Actinic Keratosis Treatment Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. Global Actinic Keratosis Treatment Market by Drug Class

3.1 Global Nucleoside Metabolic Inhibitor Market by Region
3.2 Global NSAIDs Market by Region
3.3 Global Immune Response Modifiers Market by Region
3.4 Global Photoenhancers Market by Region
3.5 Global Others Market by Region

Chapter 4. Global Actinic Keratosis Treatment Market by Therapy

4.1 Global Surgery Market by Region
4.2 Global Topical Market by Region
4.3 Global Photodynamic Therapy Market by Region

Chapter 5. Global Actinic Keratosis Treatment Market by End-use

5.1 Global Hospitals Market by Region
5.2 Global Private Clinics Market by Region
5.3 Global Homecare Market by Region
5.4 Global Others Market by Region

Chapter 6. Global Actinic Keratosis Treatment Market by Region

6.1 North America Actinic Keratosis Treatment Market
- 6.1.1 North America Actinic Keratosis Treatment Market by Drug Class
  - 6.1.1.1 North America Nucleoside Metabolic Inhibitor Market by Country
  - 6.1.1.2 North America NSAIDs Market by Country
  - 6.1.1.3 North America Immune Response Modifiers Market by Country
  - 6.1.1.4 North America Photoenhancers Market by Country
  - 6.1.1.5 North America Others Market by Country
- 6.1.2 North America Actinic Keratosis Treatment Market by Therapy
  - 6.1.2.1 North America Surgery Market by Country
  - 6.1.2.2 North America Topical Market by Country
  - 6.1.2.3 North America Photodynamic Therapy Market by Country
- 6.1.3 North America Actinic Keratosis Treatment Market by End-use
  - 6.1.3.1 North America Hospitals Market by Country
  - 6.1.3.2 North America Private Clinics Market by Country
  - 6.1.3.3 North America Homecare Market by Country
  - 6.1.3.4 North America Others Market by Country
- 6.1.4 North America Actinic Keratosis Treatment Market by Country
  - 6.1.4.1 US Actinic Keratosis Treatment Market
    - 6.1.4.1.1 US Actinic Keratosis Treatment Market by Drug Class
    - 6.1.4.1.2 US Actinic Keratosis Treatment Market by Therapy
    - 6.1.4.1.3 US Actinic Keratosis Treatment Market by End-use
  - 6.1.4.2 Canada Actinic Keratosis Treatment Market
    - 6.1.4.2.1 Canada Actinic Keratosis Treatment Market by Drug Class
    - 6.1.4.2.2 Canada Actinic Keratosis Treatment Market by Therapy
    - 6.1.4.2.3 Canada Actinic Keratosis Treatment Market by End-use
  - 6.1.4.3 Mexico Actinic Keratosis Treatment Market
    - 6.1.4.3.1 Mexico Actinic Keratosis Treatment Market by Drug Class
    - 6.1.4.3.2 Mexico Actinic Keratosis Treatment Market by Therapy
    - 6.1.4.3.3 Mexico Actinic Keratosis Treatment Market by End-use
  - 6.1.4.4 Rest of North America Actinic Keratosis Treatment Market
    - 6.1.4.4.1 Rest of North America Actinic Keratosis Treatment Market by Drug Class
    - 6.1.4.4.2 Rest of North America Actinic Keratosis Treatment Market by Therapy
    - 6.1.4.4.3 Rest of North America Actinic Keratosis Treatment Market by End-use
6.2 Europe Actinic Keratosis Treatment Market
- 6.2.1 Europe Actinic Keratosis Treatment Market by Drug Class
  - 6.2.1.1 Europe Nucleoside Metabolic Inhibitor Market by Country
  - 6.2.1.2 Europe NSAIDs Market by Country
  - 6.2.1.3 Europe Immune Response Modifiers Market by Country
  - 6.2.1.4 Europe Photoenhancers Market by Country
  - 6.2.1.5 Europe Others Market by Country
- 6.2.2 Europe Actinic Keratosis Treatment Market by Therapy
  - 6.2.2.1 Europe Surgery Market by Country
  - 6.2.2.2 Europe Topical Market by Country
  - 6.2.2.3 Europe Photodynamic Therapy Market by Country
- 6.2.3 Europe Actinic Keratosis Treatment Market by End-use
  - 6.2.3.1 Europe Hospitals Market by Country
  - 6.2.3.2 Europe Private Clinics Market by Country
  - 6.2.3.3 Europe Homecare Market by Country
  - 6.2.3.4 Europe Others Market by Country
- 6.2.4 Europe Actinic Keratosis Treatment Market by Country
  - 6.2.4.1 Germany Actinic Keratosis Treatment Market
    - 6.2.4.1.1 Germany Actinic Keratosis Treatment Market by Drug Class
    - 6.2.4.1.2 Germany Actinic Keratosis Treatment Market by Therapy
    - 6.2.4.1.3 Germany Actinic Keratosis Treatment Market by End-use
  - 6.2.4.2 UK Actinic Keratosis Treatment Market
    - 6.2.4.2.1 UK Actinic Keratosis Treatment Market by Drug Class
    - 6.2.4.2.2 UK Actinic Keratosis Treatment Market by Therapy
    - 6.2.4.2.3 UK Actinic Keratosis Treatment Market by End-use
  - 6.2.4.3 France Actinic Keratosis Treatment Market
    - 6.2.4.3.1 France Actinic Keratosis Treatment Market by Drug Class
    - 6.2.4.3.2 France Actinic Keratosis Treatment Market by Therapy
    - 6.2.4.3.3 France Actinic Keratosis Treatment Market by End-use
  - 6.2.4.4 Russia Actinic Keratosis Treatment Market
    - 6.2.4.4.1 Russia Actinic Keratosis Treatment Market by Drug Class
    - 6.2.4.4.2 Russia Actinic Keratosis Treatment Market by Therapy
    - 6.2.4.4.3 Russia Actinic Keratosis Treatment Market by End-use
  - 6.2.4.5 Spain Actinic Keratosis Treatment Market
    - 6.2.4.5.1 Spain Actinic Keratosis Treatment Market by Drug Class
    - 6.2.4.5.2 Spain Actinic Keratosis Treatment Market by Therapy
    - 6.2.4.5.3 Spain Actinic Keratosis Treatment Market by End-use
  - 6.2.4.6 Italy Actinic Keratosis Treatment Market
    - 6.2.4.6.1 Italy Actinic Keratosis Treatment Market by Drug Class
    - 6.2.4.6.2 Italy Actinic Keratosis Treatment Market by Therapy
    - 6.2.4.6.3 Italy Actinic Keratosis Treatment Market by End-use
  - 6.2.4.7 Rest of Europe Actinic Keratosis Treatment Market
    - 6.2.4.7.1 Rest of Europe Actinic Keratosis Treatment Market by Drug Class
    - 6.2.4.7.2 Rest of Europe Actinic Keratosis Treatment Market by Therapy
    - 6.2.4.7.3 Rest of Europe Actinic Keratosis Treatment Market by End-use
6.3 Asia Pacific Actinic Keratosis Treatment Market
- 6.3.1 Asia Pacific Actinic Keratosis Treatment Market by Drug Class
  - 6.3.1.1 Asia Pacific Nucleoside Metabolic Inhibitor Market by Country
  - 6.3.1.2 Asia Pacific NSAIDs Market by Country
  - 6.3.1.3 Asia Pacific Immune Response Modifiers Market by Country
  - 6.3.1.4 Asia Pacific Photoenhancers Market by Country
  - 6.3.1.5 Asia Pacific Others Market by Country
- 6.3.2 Asia Pacific Actinic Keratosis Treatment Market by Therapy
  - 6.3.2.1 Asia Pacific Surgery Market by Country
  - 6.3.2.2 Asia Pacific Topical Market by Country
  - 6.3.2.3 Asia Pacific Photodynamic Therapy Market by Country
- 6.3.3 Asia Pacific Actinic Keratosis Treatment Market by End-use
  - 6.3.3.1 Asia Pacific Hospitals Market by Country
  - 6.3.3.2 Asia Pacific Private Clinics Market by Country
  - 6.3.3.3 Asia Pacific Homecare Market by Country
  - 6.3.3.4 Asia Pacific Others Market by Country
- 6.3.4 Asia Pacific Actinic Keratosis Treatment Market by Country
  - 6.3.4.1 China Actinic Keratosis Treatment Market
    - 6.3.4.1.1 China Actinic Keratosis Treatment Market by Drug Class
    - 6.3.4.1.2 China Actinic Keratosis Treatment Market by Therapy
    - 6.3.4.1.3 China Actinic Keratosis Treatment Market by End-use
  - 6.3.4.2 Japan Actinic Keratosis Treatment Market
    - 6.3.4.2.1 Japan Actinic Keratosis Treatment Market by Drug Class
    - 6.3.4.2.2 Japan Actinic Keratosis Treatment Market by Therapy
    - 6.3.4.2.3 Japan Actinic Keratosis Treatment Market by End-use
  - 6.3.4.3 India Actinic Keratosis Treatment Market
    - 6.3.4.3.1 India Actinic Keratosis Treatment Market by Drug Class
    - 6.3.4.3.2 India Actinic Keratosis Treatment Market by Therapy
    - 6.3.4.3.3 India Actinic Keratosis Treatment Market by End-use
  - 6.3.4.4 South Korea Actinic Keratosis Treatment Market
    - 6.3.4.4.1 South Korea Actinic Keratosis Treatment Market by Drug Class
    - 6.3.4.4.2 South Korea Actinic Keratosis Treatment Market by Therapy
    - 6.3.4.4.3 South Korea Actinic Keratosis Treatment Market by End-use
  - 6.3.4.5 Singapore Actinic Keratosis Treatment Market
    - 6.3.4.5.1 Singapore Actinic Keratosis Treatment Market by Drug Class
    - 6.3.4.5.2 Singapore Actinic Keratosis Treatment Market by Therapy
    - 6.3.4.5.3 Singapore Actinic Keratosis Treatment Market by End-use
  - 6.3.4.6 Malaysia Actinic Keratosis Treatment Market
    - 6.3.4.6.1 Malaysia Actinic Keratosis Treatment Market by Drug Class
    - 6.3.4.6.2 Malaysia Actinic Keratosis Treatment Market by Therapy
    - 6.3.4.6.3 Malaysia Actinic Keratosis Treatment Market by End-use
  - 6.3.4.7 Rest of Asia Pacific Actinic Keratosis Treatment Market
    - 6.3.4.7.1 Rest of Asia Pacific Actinic Keratosis Treatment Market by Drug Class
    - 6.3.4.7.2 Rest of Asia Pacific Actinic Keratosis Treatment Market by Therapy
    - 6.3.4.7.3 Rest of Asia Pacific Actinic Keratosis Treatment Market by End-use
6.4 LAMEA Actinic Keratosis Treatment Market
- 6.4.1 LAMEA Actinic Keratosis Treatment Market by Drug Class
  - 6.4.1.1 LAMEA Nucleoside Metabolic Inhibitor Market by Country
  - 6.4.1.2 LAMEA NSAIDs Market by Country
  - 6.4.1.3 LAMEA Immune Response Modifiers Market by Country
  - 6.4.1.4 LAMEA Photoenhancers Market by Country
  - 6.4.1.5 LAMEA Others Market by Country
- 6.4.2 LAMEA Actinic Keratosis Treatment Market by Therapy
  - 6.4.2.1 LAMEA Surgery Market by Country
  - 6.4.2.2 LAMEA Topical Market by Country
  - 6.4.2.3 LAMEA Photodynamic Therapy Market by Country
- 6.4.3 LAMEA Actinic Keratosis Treatment Market by End-use
  - 6.4.3.1 LAMEA Hospitals Market by Country
  - 6.4.3.2 LAMEA Private Clinics Market by Country
  - 6.4.3.3 LAMEA Homecare Market by Country
  - 6.4.3.4 LAMEA Others Market by Country
- 6.4.4 LAMEA Actinic Keratosis Treatment Market by Country
  - 6.4.4.1 Brazil Actinic Keratosis Treatment Market
    - 6.4.4.1.1 Brazil Actinic Keratosis Treatment Market by Drug Class
    - 6.4.4.1.2 Brazil Actinic Keratosis Treatment Market by Therapy
    - 6.4.4.1.3 Brazil Actinic Keratosis Treatment Market by End-use
  - 6.4.4.2 Argentina Actinic Keratosis Treatment Market
    - 6.4.4.2.1 Argentina Actinic Keratosis Treatment Market by Drug Class
    - 6.4.4.2.2 Argentina Actinic Keratosis Treatment Market by Therapy
    - 6.4.4.2.3 Argentina Actinic Keratosis Treatment Market by End-use
  - 6.4.4.3 UAE Actinic Keratosis Treatment Market
    - 6.4.4.3.1 UAE Actinic Keratosis Treatment Market by Drug Class
    - 6.4.4.3.2 UAE Actinic Keratosis Treatment Market by Therapy
    - 6.4.4.3.3 UAE Actinic Keratosis Treatment Market by End-use
  - 6.4.4.4 Saudi Arabia Actinic Keratosis Treatment Market
    - 6.4.4.4.1 Saudi Arabia Actinic Keratosis Treatment Market by Drug Class
    - 6.4.4.4.2 Saudi Arabia Actinic Keratosis Treatment Market by Therapy
    - 6.4.4.4.3 Saudi Arabia Actinic Keratosis Treatment Market by End-use
  - 6.4.4.5 South Africa Actinic Keratosis Treatment Market
    - 6.4.4.5.1 South Africa Actinic Keratosis Treatment Market by Drug Class
    - 6.4.4.5.2 South Africa Actinic Keratosis Treatment Market by Therapy
    - 6.4.4.5.3 South Africa Actinic Keratosis Treatment Market by End-use
  - 6.4.4.6 Nigeria Actinic Keratosis Treatment Market
    - 6.4.4.6.1 Nigeria Actinic Keratosis Treatment Market by Drug Class
    - 6.4.4.6.2 Nigeria Actinic Keratosis Treatment Market by Therapy
    - 6.4.4.6.3 Nigeria Actinic Keratosis Treatment Market by End-use
  - 6.4.4.7 Rest of LAMEA Actinic Keratosis Treatment Market
    - 6.4.4.7.1 Rest of LAMEA Actinic Keratosis Treatment Market by Drug Class
    - 6.4.4.7.2 Rest of LAMEA Actinic Keratosis Treatment Market by Therapy
    - 6.4.4.7.3 Rest of LAMEA Actinic Keratosis Treatment Market by End-use

Chapter 7. Company Profiles

7.1 Almirall, S.A
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental and Regional Analysis
- 7.1.4 Research & Development Expenses
- 7.1.5 Recent strategies and developments:
  - 7.1.5.1 Partnerships, Collaborations, and Agreements:
  - 7.1.5.2 Product Launches and Product Expansions:
7.2 LEO Pharma A/S
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Regional Analysis
- 7.2.4 Research & Development Expense
- 7.2.5 Recent strategies and developments:
  - 7.2.5.1 Partnerships, Collaborations, and Agreements:
7.3 Biofrontera AG
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Research & Development Expenses
7.4 Sun Pharmaceuticals Industries Ltd.
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Regional Analysis
- 7.4.4 Research & Development Expenses
7.5 3M Company
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Segmental and Regional Analysis
- 7.5.4 Research & Development Expense
- 7.5.5 SWOT Analysis
7.6 Bausch Health Companies, Inc.
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Segmental and Regional Analysis
- 7.6.4 Research & Development Expense
7.7 Novartis AG
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Segmental and Regional Analysis
- 7.7.4 Research & Development Expense
7.8 Viatris, Inc.
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Segmental and Regional Analysis
- 7.8.4 Research & Development Expense
7.9 Galderma S.A.
- 7.9.1 Company Overview

日光角化症治療の世界市場規模、シェア、産業動向分析レポート：薬剤クラス別、治療法別、最終用途別、地域別展望と予測、2022年～2028年

Global Actinic Keratosis Treatment Market Size, Share & Industry Trends Analysis Report By Drug Class, By Therapy, By End-use, By Regional Outlook and Forecast, 2022 - 2028

目次

第1章市場の範囲と調査手法

第2章市場概要

第3章日光角化症治療の世界市場：薬物クラス別

第4章日光角化症治療の世界市場：治療法別

第5章光線力学療法の世界市場：エンドユーザー別

第6章日光角化症治療の世界市場：地域別市場

第7章企業プロファイル

LIST OF TABLES

Scope of the Study

Table of Contents

Chapter 1. Market Scope & Methodology

Chapter 2. Market Overview

Chapter 3. Global Actinic Keratosis Treatment Market by Drug Class

Chapter 4. Global Actinic Keratosis Treatment Market by Therapy

Chapter 5. Global Actinic Keratosis Treatment Market by End-use

Chapter 6. Global Actinic Keratosis Treatment Market by Region

Chapter 7. Company Profiles

日光角化症治療の世界市場規模、シェア、産業動向分析レポート：薬剤クラス別、治療法別、最終用途別、地域別展望と予測、2022年～2028年

Global Actinic Keratosis Treatment Market Size, Share & Industry Trends Analysis Report By Drug Class, By Therapy, By End-use, By Regional Outlook and Forecast, 2022 - 2028

目次

第1章 市場の範囲と調査手法

第2章 市場概要

第3章 日光角化症治療の世界市場：薬物クラス別

第4章 日光角化症治療の世界市場：治療法別

第5章 光線力学療法の世界市場：エンドユーザー別

第6章 日光角化症治療の世界市場：地域別市場

第7章 企業プロファイル

LIST OF TABLES

Scope of the Study

Table of Contents

Chapter 1. Market Scope & Methodology

Chapter 2. Market Overview

Chapter 3. Global Actinic Keratosis Treatment Market by Drug Class

Chapter 4. Global Actinic Keratosis Treatment Market by Therapy

Chapter 5. Global Actinic Keratosis Treatment Market by End-use

Chapter 6. Global Actinic Keratosis Treatment Market by Region

Chapter 7. Company Profiles

第1章市場の範囲と調査手法

第2章市場概要

第3章日光角化症治療の世界市場：薬物クラス別

第4章日光角化症治療の世界市場：治療法別

第5章光線力学療法の世界市場：エンドユーザー別

第6章日光角化症治療の世界市場：地域別市場

第7章企業プロファイル